|
神经内镜垂体腺瘤术后延迟性低钠血症的临床研究
|
Abstract:
垂体腺瘤是最常见的鞍部病变,约占颅内肿瘤的10%~15%,在颅内肿瘤中仅次于胶质瘤和脑膜瘤。垂体腺瘤来源于垂体前叶的肿瘤,大部分为良性,极少数为恶性。垂体腺瘤特指起源于垂体前叶的肿瘤,多为良性,极少发生恶变。垂体瘤可通过异常分泌激素及压迫正常的神经组织而影响病人的生活质量及寿命。一般的治疗措施包括手术切除、药物治疗及放射治疗,目前除少数对药物反应良好的垂体瘤患者外,多数患者均需接受外科手术,以彻底切除无功能性腺瘤或控制有功能性腺瘤对激素水平的影响。传统开颅手术因手术时间长,创伤较大,并且容易损伤正常脑组织,目前逐步被经鼻蝶手术取代。然而,经鼻内镜手术通道狭小、操作复杂,患者出现术后并发症风险较高,如脑脊液鼻漏、电解质平衡紊乱、尿崩症及颅内感染等。本文就神经内镜垂体腺瘤的术后出现延迟性低钠血症作一概述。
Pituitary adenoma is the most common saddle lesion, accounting for 10%~15% of intracranial tu-mors, second only to glioma and meningioma in intracranial tumors. Pituitary adenomas originate from tumors in the anterior pituitary, most of which are benign, and a few are malignant. Pituitary adenoma refers to the tumor originating from the anterior pituitary, which is mostly benign and rarely malignant. Pituitary tumors can affect the quality of life and life span of patients through ab-normal hormone secretion and compression of normal nerve tissue. The general treatment measures include surgical resection, drug treatment and radiotherapy. At present, except for a few patients with pituitary adenoma who have good drug response, most patients need to undergo sur-gery to completely remove non-functional adenoma or control the effect of functional adenoma on hormone level. Traditional craniotomy has been gradually replaced by transsphenoidal surgery due to its long operation time, large trauma and easy damage to normal brain tissue. However, due to the narrow channel and complex operation of transnasal endoscopic surgery, patients have a high risk of postoperative complications, such as cerebrospinal fluid rhinorrhea, electrolyte imbalance, diabetes insipidus and intracranial infection. This article summarizes the delayed hyponatremia after neuroendoscopic surgery for pituitary adenoma.
[1] | Yusuke, T., Kazuhiko, K., Kenichi, I., et al. (2019) Delayed Postoperative Hyponatremia after Endoscopic Transsphe-noidal Surgery for Pituitary Adenoma. Acta Neurochirurgica (Wien), 161, 707-715.
https://doi.org/10.1007/s00701-019-03818-3 |
[2] | 严正村, 张恒柱, 王晓东, 等. 神经内镜经鼻蝶窦垂体瘤手术鞍底重建策略[J]. 临床神经外科杂志, 2016, 13(2): 98. |
[3] | 黄星, 周岩, 刘祯, 等. 经鼻蝶内镜手术治疗垂体瘤卒中[J]. 中国微侵袭神经外科杂志, 2019, 24(8): 353-355. |
[4] | Lopes, M. (2017) The 2017 World Health Organi-zation Classification of Tumors of the Pituitary Gland: A Summary. Acta Neuropathologica, 134, 521-535. https://doi.org/10.1007/s00401-017-1769-8 |
[5] | Swearingen, B. (2012) Update on Pituitary Surgery. The Journal of Clinical Endocrinology & Metabolism, 97, 1073- 1081. https://doi.org/10.1210/jc.2011-3237 |
[6] | Molitch, M.E. (2017) Diagnosis and Treatment of Pituitary Adenomas: A Review. JAMA, 317, 516-524.
https://doi.org/10.1001/jama.2016.19699 |
[7] | Noronha, S., Stokes, V., Karavitaki, N., et al. (2016) Treating Pro-lactinomas with Dopamine Agonists: Always Worth the Gamble? Endocrine, 51, 205-210. https://doi.org/10.1007/s12020-015-0727-2 |
[8] | Loeffler, J.S. and Shih, H.A. (2011) Radiation Therapy in the Management of Pituitary Adenomas. The Journal of Clinical Endocrinology & Metabolism, 96, 1992-2003. https://doi.org/10.1210/jc.2011-0251 |
[9] | Ding, D., Starke, R.M. and Sheehan, J.P. (2014) Treatment Paradigms for Pituitary Adenomas: Defining the Roles of Radiosurgery and Radiation Therapy. Journal of Neuro-Oncology, 117, 445-457.
https://doi.org/10.1007/s11060-013-1262-8 |
[10] | Minniti, G., Osti, M.F. and Niyazi, M. (2016) Target Delineation and Optimal Radiosurgical Dose for Pituitary Tumors. Radiation Oncology, 11, 135. https://doi.org/10.1186/s13014-016-0710-y |
[11] | Mitsumori, M., Shrieve, D.C., Alexander, E.R., et al. (1998) Ini-tial Clinical Results of LINAC-Based Stereotactic Radiosurgery and Stereotactic Radiotherapy for Pituitary Adenomas. International Journal of Radiation Oncology, Biology, Physics, 42, 573-580. https://doi.org/10.1016/S0360-3016(98)00256-9 |
[12] | Buchfelder, M. and Kreutzer, J. (2008) Transcranial Surgery for Pituitary Adenomas. Pituitary, 11, 375-384.
https://doi.org/10.1007/s11102-008-0120-8 |
[13] | Liu, J.K., Das, K., Weiss, M.H., et al. (2001) The History and Evolution of Transsphenoidal Surgery. Journal of Neurosurgery, 95, 1083-1096. https://doi.org/10.3171/jns.2001.95.6.1083 |
[14] | Rosen, M.R., Saigal, K., Evans, J., et al. (2006) A Review of the Endoscopic Approach to the Pituitary through the Sphenoid Sinus. Current Opinion in Otolaryngology & Head and Neck Surgery, 14, 6-13.
https://doi.org/10.1097/01.moo.0000193168.46827.43 |
[15] | Razak, A.A., Horridge, M., Connolly, D.J., et al. (2013) Comparison of Endoscopic and Microscopic Trans-Sphenoidal Pituitary Surgery: Early Results in a Single Cen-tre. British Journal of Neurosurgery, 27, 40-43.
https://doi.org/10.3109/02688697.2012.703353 |
[16] | Koutourousiou, M., Gardner, P.A., Fernandez-Miranda, J.C., et al. (2013) Endoscopic Endonasal Surgery for Giant Pituitary Adenomas: Advantages and Limitations. Journal of Neurosurgery, 118, 621-631.
https://doi.org/10.3171/2012.11.JNS121190 |
[17] | Li, A., Liu, W., Cao, P., et al. (2017) Endoscopic versus Micro-scopic Transsphenoidal Surgery in the Treatment of Pituitary Adenoma: A Systematic Review and Meta-Analysis. World Neurosurgery, 101, 236-246.
https://doi.org/10.1016/j.wneu.2017.01.022 |
[18] | Patel Kunal, S., et al. (2019) Prediction of Post-Operative Delayed Hyponatremia after Endoscopic Transsphenoidal Surgery. Clinical Neurology and Neurosurgery, 182, 87-91. https://doi.org/10.1016/j.clineuro.2019.05.007 |
[19] | Bordo, G., Kelly, K., McLaughlin, N., et al. (2014) Sellar Masses that Present with Severe Hyponatremia. Endocrine Practice, 20, 1178-1186. https://doi.org/10.4158/EP13370.OR |
[20] | Yoon, H.K., Lee, H.C., Kim, Y.H., Lim, Y.J. and Park, H.P. (2019) Predictive Factors for Delayed Hyponatremia after Endoscopic Transsphenoidal Surgery in Patients with Nonfunctioning Pituitary Tumors: A Retrospective Observational Study. World Neurosurgery, 122, e1457-e1464. https://doi.org/10.1016/j.wneu.2018.11.085 |
[21] | Blair, E.T., Clemmer, J.S., Harkey, H.L., Hester, R.L. and Pruett, W.A. (2017) Physiologic Mechanisms of Water and Electrolyte Disturbances after Transsphenoidal Pituitary Surgery. World Neurosurgery, 107, 429-436.
https://doi.org/10.1016/j.wneu.2017.07.175 |
[22] | Burke, W.T., Cote, D.J., Iuliano, S.I., Zaidi, H.A. and Laws, E.R. (2018) A Practical Method for Prevention of Readmission for Symptomatic Hyponatremia Following Transsphenoidal Surgery. Pituitary, 21, 25-31.
https://doi.org/10.1007/s11102-017-0843-5 |
[23] | Alzhrani, G., Sivakumar, W., Park, M.S., et al. (2018) Delayed Complications after Transsphenoidal Surgery for Pituitary Adenomas. World Neurosurgery, 109, 233-241. https://doi.org/10.1016/j.wneu.2017.09.192 |
[24] | Taylor, S.L., Tyrrell, J.B. and Wilson, C.B. (1995) Delayed Onset of Hyponatremia after Transsphenoidal Surgery for Pituitary Adenomas. Neurosurgery, 37, 649-654. https://doi.org/10.1227/00006123-199510000-00007 |
[25] | Hensen, J., Henig, A., Fahlbusch, R., et al. (1999) Prev-alence, Predictors and Patterns of Postoperative Polyuria and Hyponatraemia in the Immediate Course after Transsphe-noidal Surgery for Pituitary Adenomas. Clinical Endocrinology (Oxford), 50, 431-439. https://doi.org/10.1046/j.1365-2265.1999.00666.x |
[26] | Zada, G., Liu, C.Y., Fishback, D., et al. (2007) Recognition and Management of Delayed Hyponatremia Following Transsphenoidal Pituitary Surgery. Journal of Neurosurgery, 106, 66-71. https://doi.org/10.3171/jns.2007.106.1.66 |
[27] | Andrews, B.T., Fitzgerald, P.A., Tyrell, J.B., et al. (1986) Cerebral Salt Wasting after Pituitary Exploration and Biopsy: Case Report. Neurosurgery, 18, 469-471. https://doi.org/10.1227/00006123-198604000-00015 |
[28] | Jahangiri, A., Wagner, J., Tran, M.T., et al. (2013) Fac-tors Predicting Postoperative Hyponatremia and Efficacy of Hyponatremia Management Strategies after More than 1000 Pituitary Operations. Journal of Neurosurgery, 119, 1478-1483. https://doi.org/10.3171/2013.7.JNS13273 |
[29] | Hussain, N.S., Piper, M., Ludlam, W.G., et al. (2013) Delayed Postoperative Hyponatremia after Transsphenoidal Surgery: Prevalence and Associated Factors. Journal of Neurosur-gery, 119, 1453-1460.
https://doi.org/10.3171/2013.8.JNS13411 |
[30] | Kelly, D.F., Laws, E.J. and Fossett, D. (1995) Delayed Hypo-natremia after Transsphenoidal Surgery for Pituitary Adenoma. Report of Nine Cases. Journal of Neurosurgery, 83, 363-367. https://doi.org/10.3171/jns.1995.83.2.0363 |
[31] | Ultmann, M.C., Hoffman, G.E., Nelson, P.B., et al. (1992) Transient Hyponatremia after Damage to the Neurohypophyseal Tracts. Neuroendocrinology, 56, 803-811. https://doi.org/10.1159/000126310 |
[32] | Palmer, B.F. (2003) Hyponatremia in Patients with Central Nervous Sys-tem Disease: SIADH versus CSW. Trends in Endocrinology and Metabolism, 14, 182-187. https://doi.org/10.1016/S1043-2760(03)00048-1 |
[33] | Tenny, S. and Thorell, W. (2018) Cerebral Salt Wasting Syndrome. |
[34] | van Tienhoven, A.J., Buikema, J.W., Veenstra, J., et al. (2018) Pitfalls in SIADH-Diagnosed Hypo-natraemia: Report of Two Cases. The Netherlands Journal of Medicine, 76, 190-193. |
[35] | Bohl, M.A., Ahmad, S., Jahnke, H., Shepherd, D., et al. (2016) Delayed Hyponatremia Is the Most Common Cause of 30-Day Unplanned Read-mission after Transsphenoidal Surgery for Pituitary Tumors. Neurosurgery, 78, 84-90.
https://doi.org/10.1227/NEU.0000000000001003 |
[36] | Krogh, J., Kistorp, C.N., Jafar-Mohammadi, B., Pal, A., Cudlip, S. and Grossman, A. (2018) Transsphenoidal Surgery for Pituitary Tumours: Frequency and Predictors of De-layed Hyponatraemia and Their Relationship to Early Readmission. European Journal of Endocrinology, 178, 247-253. https://doi.org/10.1530/EJE-17-0879 |
[37] | Winograd, D., Staggers, K.A., Sebastian, S., Takashima, M., Yoshor, D. and Samson, S.L. (2020) An Effective and Practical Fluid Restriction Protocol to Decrease the Risk of Hyponatremia and Readmissions after Transsphenoidal surgery. Neurosurgery, 87, 761-769. https://doi.org/10.1093/neuros/nyz555 |
[38] | Sorba, E.L., Staartjes, V.E., Voglis, S., Tosic, L., Brandi, G., Tschopp, O., Serra, C. and Regli, L. (2021) Diabetes Insipidus and Syndrome of Inappropriate Antidiuresis (SIADH) after Pitui-tary Surgery: Incidence and Risk Factors. Neurosurgical Review, 44, 1503-1511. https://doi.org/10.1007/s10143-020-01340-0 |
[39] | Matsuyama, J., Ikeda, H., Sato, S., Yamamoto, K., Ohashi, G. and Watanabe, K. (2014) Early Water Intake Restriction to Prevent Inappropriate Antidiuretic Hormone Secretion Fol-lowing Transsphenoidal Surgery: Low BMI Predicts Postoperative SIADH. European Journal of Endocrinology, 171, 711-716. https://doi.org/10.1530/EJE-14-0530 |
[40] | Barber, S.M., Liebelt, B.D. and Baskin, D.S. (2014) Incidence, Etiology and Outcomes of Hyponatremia after Transsphenoidal Surgery: Experience with 344 Consecutive Patients at a Single Tertiary Center. Journal of Clinical Medicine, 3, 1199-1219. https://doi.org/10.3390/jcm3041199 |
[41] | Lee, J.I., Cho, W.H., Choi, B.K., et al. (2008) Delayed Hyponatremia Following Transsphenoidal Surgery for Pituitary Ade-noma. Neurologia Medico-Chirurgica, 48, 489-492. https://doi.org/10.2176/nmc.48.489 |
[42] | Katoch, C.D., Brar, K.S. and Singh, B. (2013) Evaluation of Thyroid and Adrenal Functions in Patients with Hyponatremia. Medical Journal, Armed Forces India, 69, 237-240. https://doi.org/10.1016/j.mjafi.2013.01.003 |